TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 51 filers reported holding TALARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,587 | +12.6% | 30,458 | +21.8% | 0.00% | – |
| Q2 2023 | $76,030 | -75.2% | 25,010 | -84.7% | 0.00% | – |
| Q1 2023 | $307,120 | +80.7% | 163,362 | -2.0% | 0.00% | – |
| Q4 2022 | $170,004 | -62.8% | 166,670 | -4.1% | 0.00% | – |
| Q3 2022 | $457,000 | -37.7% | 173,738 | +6.8% | 0.00% | – |
| Q2 2022 | $734,000 | -54.6% | 162,683 | -1.0% | 0.00% | – |
| Q1 2022 | $1,618,000 | -37.0% | 164,342 | -2.2% | 0.00% | – |
| Q4 2021 | $2,569,000 | +128.4% | 168,045 | +102.5% | 0.00% | – |
| Q3 2021 | $1,125,000 | -17.5% | 82,987 | -10.6% | 0.00% | – |
| Q2 2021 | $1,363,000 | – | 92,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $7,713,000 | 11.20% |
| Aisling Capital Management LP | 175,000 | $460,000 | 0.30% |
| Artal Group S.A. | 2,064,262 | $5,429,000 | 0.23% |
| Cormorant Asset Management, LP | 900,649 | $2,369,000 | 0.17% |
| Eventide Asset Management | 1,561,092 | $4,106,000 | 0.08% |
| Blackstone Inc. | 8,089,315 | $21,275 | 0.08% |
| Logos Global Management LP | 197,913 | $521,000 | 0.06% |
| Values First Advisors, Inc. | 30,715 | $81,000 | 0.06% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $8,652,000 | 0.04% |
| CAAS CAPITAL MANAGEMENT LP | 297,707 | $783,000 | 0.04% |